Global Protein Therapeutics Market Forecast to 2015


April 1, 2012
160 Pages - SKU: CICQ3824285
License type:
Countries covered: Global

Protein-based therapies have found a prominent place in the biopharmaceutical industry since the launch of human insulin product. They have become one of the most effective clinical methods to treat wide spectrum of diseases, ranging from cancer to metabolic disorders. Despite the post-recessionary impact worldwide causing major slump in the healthcare spending, the protein therapeutics market continued to grow at its retained speed. According to our report, the market still holds tremendous growth potential and it is estimated that by 2015-end, it may reach the mark of US$ 143.4 Billion as new products, especially monoclonal antibodies in the advanced clinical phase, may enter the market.

Our new research report, “Global Protein Therapeutics Market Forecast to 2015”, found that a large number of market players have been developing monoclonal antibodies (mAbs)-based therapies. The mAb products contribute one of the largest shares in the number of protein therapeutic products under pipeline. The report, in this context, gives a comprehensive analysis of the current and future patterns of revenue generation with respect to mAbs and other segments.

Through in-depth and prudent analysis of the developments taking place at the global level, we have observed that the US holds a dominant position in the global protein therapeutics market as the country provides a major proportion of products’ sales. However, our team of researchers has come up with an analysis that the future landscape of the market may find positive developments from the Asian countries as huge patient population and increasing disposable income may turn out to be a win-win condition for industry participants.

Our report takes into account all the key aspects of the worldwide protein therapeutics market and projects the market for the period 2012-2015. It prudently analyzes industry segments in an effective manner by focusing on major players and products, recent developments, application support in terms of indications, geographical performance and last but not the least, current and future market size. Moreover, it summarizes the recent trends which may have an impact on the industry’s future performance. Overall, the report will prove to be a complete source of knowledge and analysis for clients and potential investors.



More Antibody Technologies reports by RNCOS

Cancer Monoclonal Antibodies Market to 2015 by RNCOS
Globally, cancer is one of the leading causes of death, and accounted for almost 13% of total deaths in 2008. The cases of lung and ...
Global Monoclonal Antibody Market Analysis by RNCOS
Considered as an indispensable tool in the clinical and biotechnology sector, monoclonal antibodies have testified to be useful in the diagnosis and treatment of many ...
See all reports like this >>

More Global Antibody Technologies reports

Protein Engineering Market [Products (Monoclonal Antibody, Insulin Analog, Modified EPO), Technology (Sequential Modification, Glycosylation, PEGylation), and Applications (Therapeutics, Diagnostics, Research)] - Global Forecast to 2017 by MarketsandMarkets
Proteins exhibit high specificity and less immunogenicity and are widely used as therapeutic agents in the treatment of various disorders and diseases. There are more ...
Ion Channel Modulators by Global Industry Analysts
Ion Channel Modulators, by GIA, analyzes the worldwide markets for Ion Channel Modulators in US$ Million. The report provides separate comprehensive analytics for the US, ...
Global and China Monoclonal Antibody Industry Report, 2013 by Research in China
In recent years, the monoclonal antibody market around the globe has witnessed substantial growth, and the CAGR of market scale during 1997-2011 has reached 44% ...
Single-Use Technologies for Biopharmaceuticals: Global Markets by BCC Research
This report provides: An overview of biopharmaceutical single-use technologies, which aids the manufacturing process in overcoming such complex issues as sterilization and critical manufacturing parameters ...
See all reports like this >>